MedTrace Logo

Clinical Evaluation of Two Daily Disposable Lenses in Sphere Design

NCT05516082 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2023-11-28

Study results available
· View outcomes & findings →

Summary

This was a single-blind, interventional, prospective, direct refit, bilateral wear, fixed-sequence crossover study.

Conditions

  • Ametropia

Interventions

DEVICE

Lens A

DDH contact lens for 15 minutes

DEVICE

Lens B

DDSH contact lens for 15 minutes

Sponsors & Collaborators

  • CooperVision, Inc.

    lead INDUSTRY

Principal Investigators

  • Rubén V Guerrero, MSc., FIACLE · Dr. Ruben Velazquez Private Practice

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-08
Primary Completion
2022-10-12
Completion
2022-10-12
FDA Device
Yes

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05516082 on ClinicalTrials.gov